25 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
identity, strength, quality and purity;
potential inspection of selected clinical investigation sites to assess compliance with GCPs; and
FDA review … on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations
8-K
EX-99.1
NMRA
Neumora Therapeutics Inc.
8 Jan 24
Regulation FD Disclosure
8:32am
Human t30 hours 30 – 40 hours Under investigation 1/2 6 *175 µg/kg was the highest dose used to estimate Kappa receptor occupancy in nonhuman
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
, including:
the size and nature of the patient population;
the severity of the disease under investigation;
eligibility criteria for the trial … to permit the import or export of products, or require us to conduct a product recall.
Any government investigation of alleged violations of law could
S-1/A
EX-10.13
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing, or any other actual, threatened
S-1/A
EX-1.1
dj7vem9
11 Sep 23
IPO registration (amended)
6:07am
S-1/A
hdt an2hd4st32
11 Sep 23
IPO registration (amended)
6:07am
S-1
2cv0fqvu 09053vw
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.2
6bpszhtu pi6uy
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.3
0nmngqm1
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.5
hdge3fq59qtqw9h2nxh9
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.4
oct cjqjfeq
25 Aug 23
IPO registration
5:03pm
S-1
EX-2.1
9w8 rte2l
25 Aug 23
IPO registration
5:03pm
S-1
EX-10.18
y9v6m3tj
25 Aug 23
IPO registration
5:03pm
DRS/A
3og6wrnze ui7or3h1tr
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
EX-10.19
px59v6u0f9j5l
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
d45dl
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
zoix9izl
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
hkxf19ndu lgt
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
cnw91ndjlu
10 Jun 22
Draft registration statement (amended)
12:00am